Status:
UNKNOWN
The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome
Lead Sponsor:
University of Khartoum
Collaborating Sponsors:
Awad, Mohamed Ibrahim, M.D.
Duria abdulwahab Elrrayes
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-40 years
Phase:
PHASE1
PHASE2
Brief Summary
An open clinical trial
Detailed Description
The patients with PCOS will be recruited to receive folic acid (45 patients) and equal number will receive no folic acid
Eligibility Criteria
Inclusion
- Patients who will visit this centre suffering from PCOS-related subfertility will be invited to be enrolled to this study if met the Rotterdam criteria for the diagnosis of PCOS
Exclusion
- The patients whom will be excluded from the study are those comorbid with hyperprolactinemia, congenital adrenal hyperplasia, diabetes mellitus, significant cardiovascular problems, thyroid dysfunctions, unresolved medical conditions, or using medications suspected to affect reproductive or metabolic functions within two months of the study entry.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03268733
Start Date
September 1 2017
End Date
September 1 2019
Last Update
August 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saad Abul ella fertility Centre
Khartoum, Sudan, 11111